SCHEMBL7965519

SCHEMBL7965519

CC(C)(C)c1ccccc1OCCCN1CCC(O)(c2cnc3ccccc3c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
GAA P10253 2/20 0.46
LMNA P02545 1/20 0.41
IGF1R P08069 1/20 0.40
CCR1 P32246 1/20 0.39
HTT P42858 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.39
DRD2 P14416 4/20 0.39
HTR1A P08908 3/20 0.39
HTR7 P34969 3/20 0.39
HTR2A P28223 2/20 0.39
DRD1 P21728 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966346 0.83 CYP2D6 (0.49) ALDH1A1CYP1A2CYP2D6MEN1KMT2A
SCHEMBL7964899 0.83 ALDH1A1 (0.50) ALDH1A1CYP2D6CYP2C19MEN1KMT2A
SCHEMBL7962754 0.83 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ALMNAIGF1R
SCHEMBL7963819 0.81 MAOA (0.46) MAPTLMNACCR1TP53DRD2
SCHEMBL7970239 0.80 GAA (0.43) MEN1KMT2AMAPTGAALMNA
Oxalic Acid SCHEMBL7966500 0.80 KMT2A (0.52) ALDH1A1CYP1A2CYP2D6MEN1KMT2A
SCHEMBL7967101 0.80 HTR1A (0.40) HTR1AHTR7HTR2ASLC6A4DRD3
SCHEMBL7964658 0.80 MEN1 (0.48) ALDH1A1MEN1KMT2ALMNAIGF1R
Oxalic Acid SCHEMBL7966526 0.79 KDM4E (0.54) ALDH1A1MEN1KMT2ALMNADRD2
Oxalic Acid SCHEMBL7965012 0.77 KDM4E (0.46) ALDH1A1CCR1DRD2HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed